BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33512805)

  • 1. Relationship of the Esophageal Microbiome and Tissue Gene Expression and Links to the Oral Microbiome: A Randomized Clinical Trial.
    Annavajhala MK; May M; Compres G; Freedberg DE; Graham R; Stump S; Que J; Korem T; Uhlemann AC; Abrams JA
    Clin Transl Gastroenterol; 2020 Dec; 11(12):e00235. PubMed ID: 33512805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosa-Associated Microbiota in Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma Differ Similarly Compared With Healthy Controls.
    Peter S; Pendergraft A; VanDerPol W; Wilcox CM; Kyanam Kabir Baig KR; Morrow C; Izard J; Mannon PJ
    Clin Transl Gastroenterol; 2020 Aug; 11(8):e00199. PubMed ID: 32955191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-Microbiota Interactions in the Esophagus During Homeostasis and Allergic Inflammation.
    Brusilovsky M; Bao R; Rochman M; Kemter AM; Nagler CR; Rothenberg ME
    Gastroenterology; 2022 Feb; 162(2):521-534.e8. PubMed ID: 34627858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome.
    Yang L; Lu X; Nossa CW; Francois F; Peek RM; Pei Z
    Gastroenterology; 2009 Aug; 137(2):588-97. PubMed ID: 19394334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Esophageal Microbiome in Health and Disease.
    Corning B; Copland AP; Frye JW
    Curr Gastroenterol Rep; 2018 Aug; 20(8):39. PubMed ID: 30069679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma.
    Lv J; Guo L; Liu JJ; Zhao HP; Zhang J; Wang JH
    World J Gastroenterol; 2019 May; 25(18):2149-2161. PubMed ID: 31143067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights Into the Oral Microbiome and Barrett's Esophagus Early Detection: A Narrative Review.
    Zhang Z; Curran G; Altinok Dindar D; Wu Y; Wu H; Sharpton T; Zhao L; Lieberman D; Otaki F
    Clin Transl Gastroenterol; 2021 Aug; 12(9):e00390. PubMed ID: 34446641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Salivary Microbiome Is Altered in Children With Eosinophilic Esophagitis and Correlates With Disease Activity.
    Hiremath G; Shilts MH; Boone HH; Correa H; Acra S; Tovchigrechko A; Rajagopala SV; Das SR
    Clin Transl Gastroenterol; 2019 Jun; 10(6):e00039. PubMed ID: 31107724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of esophageal eosinophils in patients with Barrett's esophagus.
    Ravi K; Katzka DA; Smyrk TC; Prasad GA; Romero Y; Francis DL; Lutzke L; Tian J; Wang KK
    Am J Gastroenterol; 2011 May; 106(5):851-7. PubMed ID: 21304498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophageal microbiome in eosinophilic esophagitis.
    Harris JK; Fang R; Wagner BD; Choe HN; Kelly CJ; Schroeder S; Moore W; Stevens MJ; Yeckes A; Amsden K; Kagalwalla AF; Zalewski A; Hirano I; Gonsalves N; Henry LN; Masterson JC; Robertson CE; Leung DY; Pace NR; Ackerman SJ; Furuta GT; Fillon SA
    PLoS One; 2015; 10(5):e0128346. PubMed ID: 26020633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma.
    Snider EJ; Freedberg DE; Abrams JA
    Dig Dis Sci; 2016 Aug; 61(8):2217-2225. PubMed ID: 27068172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations to the Esophageal Microbiome Associated with Progression from Barrett's Esophagus to Esophageal Adenocarcinoma.
    Snider EJ; Compres G; Freedberg DE; Khiabanian H; Nobel YR; Stump S; Uhlemann AC; Lightdale CJ; Abrams JA
    Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1687-1693. PubMed ID: 31466948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of non-erosive reflux disease and dynamics of the esophageal microbiome: a prospective multicenter study.
    Park CH; Seo SI; Kim JS; Kang SH; Kim BJ; Choi YJ; Byun HJ; Yoon JH; Lee SK
    Sci Rep; 2020 Sep; 10(1):15154. PubMed ID: 32938975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cultivable bacterial flora of the esophagus in subjects with esophagitis.
    Norder Grusell E; Dahlén G; Ruth M; Bergquist H; Bove M
    Scand J Gastroenterol; 2018 Jun; 53(6):650-656. PubMed ID: 29616839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus.
    Yang L; Francois F; Pei Z
    Clin Cancer Res; 2012 Apr; 18(8):2138-44. PubMed ID: 22344232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
    Triadafilopoulos G; Kaczynska M; Iwane M
    Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microscopic esophagitis and Barrett's esophagus: the histology report.
    Fiocca R; Mastracci L; Milione M; Parente P; Savarino V; ;
    Dig Liver Dis; 2011 Mar; 43 Suppl 4():S319-30. PubMed ID: 21459338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of esophageal inflammation, obesity and gastroesophageal reflux disease: from FDG PET/CT perspective.
    Wu YW; Tseng PH; Lee YC; Wang SY; Chiu HM; Tu CH; Wang HP; Lin JT; Wu MS; Yang WS
    PLoS One; 2014; 9(3):e92001. PubMed ID: 24642729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett's Esophagus via Interleukin 8 and Alterations to the Gut Microbiome.
    Münch NS; Fang HY; Ingermann J; Maurer HC; Anand A; Kellner V; Sahm V; Wiethaler M; Baumeister T; Wein F; Einwächter H; Bolze F; Klingenspor M; Haller D; Kavanagh M; Lysaght J; Friedman R; Dannenberg AJ; Pollak M; Holt PR; Muthupalani S; Fox JG; Whary MT; Lee Y; Ren TY; Elliot R; Fitzgerald R; Steiger K; Schmid RM; Wang TC; Quante M
    Gastroenterology; 2019 Aug; 157(2):492-506.e2. PubMed ID: 30998992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.